ArticleScientific reports2026
Systematic optimization and characterization of bacterial depolymerization of poly(ethylene terephthalate) plastics.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biodepolymerization of poly(ethylene terephthalate) (PET) plastics using microorganisms has emerged as a promising and sustainable approach for mitigating pollution caused by PET waste. In this study, Glutamicibacter mysorens ASR14, a mesophilic bacterium isolated from Kodungaiyur dumpyard (Chennai, India), showed 27.6% PET biodepolymerization in terms of weight loss in 30 d. A customized screening of 20 trials was designed using JMP statistical software to evaluate the influence of various variables. Furthermore, a Central Composite Design (CCD) of Response Surface Methodology (RSM) was adopted and validated using four variables at five levels, with 25 trials, to correlate the relationship for enhanced PET biodepolymerization. A maximum PET weight loss of 75.6% was achieved in 60 d, representing a 2.73-fold improvement compared to that under unoptimized conditions. Enzymatic assays confirmed the involvement of esterase (5,690 U/mL) and lipase (962 U/mL) activities in accelerating the breakdown of PET. The analytical characterization techniques revealed significant surface erosion, reduction in crystallinity, and high yield of terephthalic acid (TPA), which also holds potential value for biorefinery applications. This work represents the first comprehensive report on process optimization for PET biodepolymerization using G. mysorens ASR14 as a whole-cell biocatalyst. The findings establish G. mysorens ASR14 as a promising candidate for developing scalable, green bioremediation strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.